CD151 Maintains Endolysosomal Protein Quality to Inhibit Vascular Inflammation

Junxiong Chen(University of Science and Technology of China), Xin A. Zhang(University of Oklahoma Health Sciences Center), Chao Huang(Tongji University), Dao Wen Wang(Tongji Hospital), Rongmei Qu(Southern Medical University), Yingjun Ding(Hi-Z Technology (United States)), Heather C. Rice(University of Oklahoma Health Sciences Center), Constantin Georgescu(Oklahoma Medical Research Foundation), Subramaniyan Bharathiraja(Tamil Nadu Agricultural University), James F. Papin(University of Oklahoma Health Sciences Center), Franklin A. Hays(University of Oklahoma Health Sciences Center), Arnoud Sonnenberg(The Netherlands Cancer Institute), Tomoharu Kanie(University of Oklahoma Health Sciences Center), You‐Yang Zhao(Northwestern University), Christopher S. Stipp(University of Iowa), Matthew S. Walters(Cornell University), Cory B. Giles(Oklahoma Medical Research Foundation), Christoph H. Mayr(Boehringer Ingelheim (Germany)), David Wu(Teach For America), Jie Wang(Jishou University), Beibei Liu(Chinese Academy of Sciences), Xuejun Wang(Tianjin Medical University Cancer Institute and Hospital), Houjuan Zuo(Tongji Hospital), Chao Jiang(Fuzhou Maternity and Child Health Care Hospital), Jingxing Dai(Southern Medical University), Kar‐Ming Fung(University of Oklahoma Health Sciences Center), Herbert B. Schiller(Helmholtz Zentrum München), Darlene Reuter(University of Oklahoma Health Sciences Center), Jonathan D. Wren(Oklahoma Medical Research Foundation)
Circulation Research
April 1, 2024
Cited by 13


Related Papers